PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 61 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

6 October 2024

  1. (diff | hist) m b 16:58 SELECT trial 2,328 +28 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) 16:25 Chinese Peptide Company 4,319 ±0 UnderfillUna (talk | contribs) expand §Corporate identity and history [rollback]
  3. (diff | hist) m b 15:01 Liraglutide 3,239 +135 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  4. (diff | hist) 11:28 Number needed to treat 1,122 ±0 AnalyticalAnnie (talk | contribs) add the PMID [rollback]
  5. (diff | hist) 10:48 Exenatide 1,276 ±0 LiraLotte (talk | contribs) ce [rollback]
  6. (diff | hist) 10:29 Talk:Reconstitution calculator 1,244 +80 DrTitration (talk | contribs) /* Does this page cross the line into instruction? */ reply
  7. (diff | hist) m 06:56 Loss on drying 2,274 +37 PancreasPru (talk | contribs) split §Principle from §Practical limitations [rollback]
  8. (diff | hist) m 05:56 Haemoglobin A1c 2,574 ±0 ComparisonCato (talk | contribs) correct the reference interval — the source gives it for fasting samples [rollback]
  9. (diff | hist) m 04:55 Custom peptide synthesis 2,139 ±0 StopperingSteff (talk | contribs) fix a broken wikilink [rollback]
  10. (diff | hist) 04:49 GLP-1 receptor 4,864 +997 GIP_Genoveva (talk | contribs) typo [rollback]
  11. (diff | hist) 03:21 Incretin effect 4,803 +754 CapitalisationCaz (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  12. (diff | hist) m 00:41 Fasting insulin 1,662 ±0 DEXA_Dilys (talk | contribs) expand §Standardisation [rollback]

5 October 2024

  1. (diff | hist) m 21:03 Good manufacturing practice 2,439 +666 Chromatokid (talk | contribs) add the customs-detention point with its source [rollback]
  2. (diff | hist) 14:52 Talk:Reconstitution calculator 1,033 +195 UnitsUrsula (talk | contribs) /* Does this page cross the line into instruction? */ reply
  3. (diff | hist) 11:09 SURMOUNT trial programme 2,567 ±0 LeaderLoic (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  4. (diff | hist) 10:26 Amylin receptor agonist 1,601 ±0 MassSpecMarv (talk | contribs) add short description [rollback]
  5. (diff | hist) m b 10:07 Albumin binding half-life extension 2,821 +396 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 09:17 Peptide supply chain 1,378 ±0 DrTitration (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  7. (diff | hist) m b 08:49 Dipeptidyl peptidase-4 3,295 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  8. (diff | hist) 08:45 Enteroendocrine L cell 3,351 +305 CDMO_Caradoc (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  9. (diff | hist) 07:49 HOMA-IR 1,590 +177 LabRangeLindy (talk | contribs) add the body-composition measurement method to the comparison [rollback]
  10. (diff | hist) 07:25 Cagrilintide 2,406 +304 ComparisonCato (talk | contribs) British spelling per PP:MOS [rollback]
  11. (diff | hist) 05:42 Nantong Guangyuan Chemical 5,712 +681 DeletionDeb (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  12. (diff | hist) 04:24 Analytical method validation 2,979 ±0 PeakShapePol (talk | contribs) expand §The characteristics [rollback]
  13. (diff | hist) m 01:25 Sterile water for injection 2,419 +393 DeadSpaceDot (talk | contribs) expand §Compendial requirements [rollback]
  14. (diff | hist) 00:48 PeptideMeter 2,760 +33 MassSpecMarv (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]

4 October 2024

  1. (diff | hist) 19:55 Wuhan Wansheng Biotechnology 6,072 +532 DrTitration (talk | contribs) expand §Ordering and availability [rollback]
  2. (diff | hist) N 17:50 Peptide supply chain 1,378 +1,378 TrialsTabitha (talk | contribs) start article on the process step
  3. (diff | hist) 17:08 SURPASS trial programme 2,611 ±0 TrialsTabitha (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 16:23 Hunan Aslsen Technology 2,610 +610 AnalyticalAnnie (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  5. (diff | hist) 14:08 Sterility testing 1,908 ±0 AnalyticalAnnie (talk | contribs) add the plate-count expression and define its terms [rollback]
  6. (diff | hist) 12:57 Research use only 3,527 ±0 TechnicianTeal (talk | contribs) correct the description of the research-use-only exemption [rollback]
  7. (diff | hist) 11:55 Liquid chromatography-mass spectrometry 2,132 ±0 BlindSampleBrid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  8. (diff | hist) m 11:26 Prescribing information 2,203 +272 Peptide_Pete (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  9. (diff | hist) m 10:51 Cold chain 11,290 +477 FmocFrancis (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  10. (diff | hist) 08:58 Dual incretin agonist 3,231 ±0 API_Aurora (talk | contribs) add see also to the amylin analogue [rollback]
  11. (diff | hist) 06:27 List of GLP-1 receptor agonists 2,257 ±0 PortalPolly (talk | contribs) de-duplicate a repeated sentence [rollback]

3 October 2024

  1. (diff | hist) m b 18:47 Preparative HPLC purification 2,696 +388 StubSorterBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 17:01 Certificate of analysis 3,722 +236 HarmReductionHen (talk | contribs) convert a hard-coded date to the house format [rollback]
  3. (diff | hist) 14:23 Triple agonist 2,043 ±0 NPOV_Nadia (talk | contribs) add the receptor targets to the lead sentence [rollback]
  4. (diff | hist) 11:29 Vial 9,207 +1,409 ResinRhoswen (talk | contribs) expand §Delamination and glass defects [rollback]
  5. (diff | hist) 08:07 Talk:Reconstitution calculator 822 +271 Ref_Desk_Ron (talk | contribs) /* Does this page cross the line into instruction? */ reply
  6. (diff | hist) m 05:46 Guangzhou JEEP Biotechnology 5,366 +729 DeadSpaceDot (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]

2 October 2024

  1. (diff | hist) m b 20:19 Peptide synthesis 2,919 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 19:13 Crude peptide 1,870 ±0 FmocFrancis (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  3. (diff | hist) 18:39 Repackaging 1,833 ±0 DiagramDelphine (talk | contribs) expand §Environmental exposure during transfer [rollback]
  4. (diff | hist) m 12:40 High-performance liquid chromatography 3,326 ±0 Areapercent_Ayo (talk | contribs) expand §Why method conditions must be stated [rollback]
  5. (diff | hist) 11:52 Electrospray ionisation 1,979 ±0 TechnicianTeal (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  6. (diff | hist) 11:18 Talk:Reconstitution calculator 611 +397 DrTitration (talk | contribs) /* Does this page cross the line into instruction? */ reply
  7. (diff | hist) 09:41 Talk:Reconstitution calculator 400 +504 Ref_Desk_Ron (talk | contribs) /* Does this page cross the line into instruction? */ new section
  8. (diff | hist) N 09:00 Amylin receptor agonist 1,601 +1,601 TimelineTiernan (talk | contribs) start article on the compound
  9. (diff | hist) N 06:58 Custom peptide synthesis 2,139 +2,139 Ref_Desk_Ron (talk | contribs) new article: supply and handling, expansion welcome
  10. (diff | hist) m b 03:32 Bacteriostatic water 2,807 ±0 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]

1 October 2024

  1. (diff | hist) 21:39 Trifluoroacetate counterion 2,098 ±0 DiluentDiya (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  2. (diff | hist) 19:31 Blind sampling 2,967 +26 PrimarySrcPatia (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]
  3. (diff | hist) 15:00 Janoshik Analytical 2,971 +127 LeaderLoic (talk | contribs) clarify that a signature on a certificate is a release, not a verification [rollback]
  4. (diff | hist) 12:07 ISO 9001 2,417 +450 LiraLotte (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  5. (diff | hist) 11:02 Arcuate nucleus 2,347 +1,076 MolarMassMaeve (talk | contribs) fix hyphenation per PP:MOS [rollback]
  6. (diff | hist) m b 08:38 Peptide content 2,529 +574 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) m 07:49 Bachem Holding (Suzhou) 1,686 ±0 LabelLibby (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  8. (diff | hist) 05:50 Chain of custody 2,414 ±0 ChainCustodyChad (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  9. (diff | hist) N 00:49 HOMA-IR 1,413 +1,413 ApoB_Aurelio (talk | contribs) new article: laboratory medicine, expansion welcome

30 September 2024

  1. (diff | hist) m 21:36 Adverse effects of GLP-1 receptor agonists 3,137 ±0 AppealsArno (talk | contribs) add category for adverse effects [rollback]
  2. (diff | hist) 21:16 Dulaglutide 1,910 ±0 SurvodutideSaff (talk | contribs) add the peptide length to the infobox [rollback]
  3. (diff | hist) 20:44 Solid-phase peptide synthesis 2,718 ±0 StopperingSteff (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  4. (diff | hist) 11:52 Qingdao Sigma Chemical 4,241 +1,443 PlainNumbersPip (talk | contribs) space between number and unit per PP:MOS [rollback]
  5. (diff | hist) N 09:00 Repackaging 1,833 +1,833 PrepHPLC_Pia (talk | contribs) create article — process stub
  6. (diff | hist) 07:46 Amylin 1,974 ±0 SemaglutideSasha (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  7. (diff | hist) 03:33 FLOW trial 1,198 ±0 LeanMassLars (talk | contribs) expand §Results [rollback]

29 September 2024

  1. (diff | hist) 20:01 Missed dose 1,432 ±0 MicrodoseMagnus (talk | contribs) add the note about drawing air before withdrawal [rollback]
  2. (diff | hist) m 17:21 Insulin syringe 2,649 ±0 DeadSpaceDot (talk | contribs) rm the brand-specific instruction; it is not general [rollback]
  3. (diff | hist) N 09:00 Number needed to treat 1,122 +1,122 Chromatokid (talk | contribs) new article: trial programme, expansion welcome
  4. (diff | hist) 07:01 Reconstitution of lyophilised peptides 2,961 ±0 LyophilLena (talk | contribs) correct the label on the second column — that is volume, not mass [rollback]
  5. (diff | hist) m b 03:23 C-peptide 2,506 +334 CategoryBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) m 02:38 Semaglutide 5,011 ±0 OrforglipronOona (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]

28 September 2024

  1. (diff | hist) m 22:19 WuXi TIDES 4,428 +33 VerifyVesna (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  2. (diff | hist) 20:00 Tirzepatide 4,706 +840 SelectTrialSam (talk | contribs) add category for the drug class [rollback]
  3. (diff | hist) 18:19 Receptor bias 1,938 ±0 TalkPageTaro (talk | contribs) de-orphan [rollback]
  4. (diff | hist) m 16:15 Exenatide 1,276 ±0 SecretagogueSol (talk | contribs) expand §Origin and sequence [rollback]
  5. (diff | hist) m b 16:09 Beta cell function 2,746 +455 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  6. (diff | hist) m 11:03 Injection site rotation 2,155 ±0 StabilityStig (talk | contribs) add the beyond-use interval with the storage condition it assumes [rollback]
  7. (diff | hist) 09:31 Insulin secretion 3,806 +1,094 CuriousCallum (talk | contribs) name the enzyme responsible for the cleavage at the first mention [rollback]
  8. (diff | hist) m 07:53 Sterility testing 1,908 ±0 IsocraticIla (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  9. (diff | hist) 07:35 Reference standard 2,872 ±0 Chromatokid (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  10. (diff | hist) m b 06:44 VendorInvestigate 2,593 +403 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  11. (diff | hist) 02:38 STEP trial programme 3,324 ±0 CRP_Cormac (talk | contribs) sentence case in headings per PP:MOS [rollback]

27 September 2024

  1. (diff | hist) 19:40 Third-party testing 4,307 +754 GroupBuyGalen (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 19:37 TRIUMPH trial programme 1,956 +739 EpitalonEoin (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]
  3. (diff | hist) 16:34 Satiety signalling 2,746 +576 RepackRadek (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  4. (diff | hist) m 16:18 Bacterial endotoxin test 2,424 +297 KarlFischerKit (talk | contribs) add the counterion determination method by name [rollback]
  5. (diff | hist) 14:36 Residual solvent 1,962 ±0 SecretagogueSol (talk | contribs) expand §Determination and its blind spots [rollback]
  6. (diff | hist) N 09:00 Bachem Holding (Suzhou) 1,686 +1,686 MolarMassMaeve (talk | contribs) create organisation article per PP:VN
  7. (diff | hist) m b 07:43 Lyophilisation 4,631 +607 CategoryBot (talk | contribs) bot: normalise temperature formatting [rollback]
  8. (diff | hist) m 07:05 Weight regain after discontinuation 1,814 ±0 AnaesthesiaAoife (talk | contribs) unpipe a link that did not need piping [rollback]
  9. (diff | hist) m 07:04 Karl Fischer titration 4,481 +308 PBM_Perrin (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  10. (diff | hist) 05:57 Retention time 2,027 +407 SemaxSevi (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  11. (diff | hist) 00:39 Fmoc chemistry 2,683 +31 PrepHPLC_Pia (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]

26 September 2024

  1. (diff | hist) 23:45 Crude peptide 1,870 ±0 INN_Ingrid (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  2. (diff | hist) 20:12 Chinese Peptide Company 4,319 +207 ReportReaderRilla (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  3. (diff | hist) 19:14 GL Biochem (Shanghai) 6,902 +511 UnderfillUna (talk | contribs) expand §Product range [rollback]